119 related articles for article (PubMed ID: 16377939)
1. Newborn infant with maternal anti-SSA antibody-induced complete heart block accompanying cardiomyopathy.
Iida M; Inamura N; Takeuchi M
Circ J; 2006 Jan; 70(1):147-9. PubMed ID: 16377939
[TBL] [Abstract][Full Text] [Related]
2. Fetal echocardiographic assessment of endocardial fibroelastosis in maternal anti-SSA antibody-associated complete heart block.
Aoki H; Inamura N; Kawazu Y; Nakayama M; Kayatani F
Circ J; 2011; 75(5):1215-21. PubMed ID: 21436591
[TBL] [Abstract][Full Text] [Related]
3. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options.
Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Piette JC
Arthritis Res Ther; 2005; 7(2):69-73. PubMed ID: 15743492
[TBL] [Abstract][Full Text] [Related]
4. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis.
van der Leij JN; Visser GH; Bink-Boelkens MT; Meilof JF; Kallenberg CG
Prenat Diagn; 1994 Oct; 14(10):1003-7. PubMed ID: 7899264
[TBL] [Abstract][Full Text] [Related]
5. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
[TBL] [Abstract][Full Text] [Related]
6. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
[TBL] [Abstract][Full Text] [Related]
7. Neonatal lupus erythematosus complicated by improved congenital complete heart block.
Isayama T; Inamura N; Shiono N; Kitajima H
Pediatr Int; 2013 Aug; 55(4):521-4. PubMed ID: 23910804
[TBL] [Abstract][Full Text] [Related]
8. Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report.
Louthrenoo W; Boonyaratavej S; Sittiwangkul R; Sukitawut W
J Med Assoc Thai; 1998 Aug; 81(8):633-6. PubMed ID: 9737117
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune congenital heart block: complex and unusual situations.
Brito-Zerón P; Izmirly PM; Ramos-Casals M; Buyon JP; Khamashta MA
Lupus; 2016 Feb; 25(2):116-28. PubMed ID: 26762645
[TBL] [Abstract][Full Text] [Related]
10. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
Clancy RM; Buyon JP
Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
[TBL] [Abstract][Full Text] [Related]
11. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
[TBL] [Abstract][Full Text] [Related]
12. Congenital complete heart block and maternal connective tissue disease.
Jayaprasad N; Johnson F; Venugopal K
Int J Cardiol; 2006 Sep; 112(2):153-8. PubMed ID: 16815568
[TBL] [Abstract][Full Text] [Related]
13. An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease.
Cuneo BF; Strasburger JF; Niksch A; Ovadia M; Wakai RT
J Matern Fetal Neonatal Med; 2009 Mar; 22(3):233-8. PubMed ID: 19330707
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease.
Cuneo BF; Fruitman D; Benson DW; Ngan BY; Liske MR; Wahren-Herlineus M; Ho SY; Jaeggi E
Am J Cardiol; 2011 Mar; 107(5):761-6. PubMed ID: 21247531
[TBL] [Abstract][Full Text] [Related]
15. Successful outcome in a fetus with an extremely low heart rate due to isolated complete congenital heart block.
Vesel S; Zavrsnik T; Podnar T
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):189-91. PubMed ID: 12601845
[TBL] [Abstract][Full Text] [Related]
16. Positive maternal anti-SSA/SSB antibody-related fetal right ventricular endocardial fibroelastosis without atrioventricular block, reversal of endocardial fibroelastosis.
Pises N; Acherman RJ; Iriye BK; Rollins RC; Castillo W; Herceg E; Evans WN
Prenat Diagn; 2009 Feb; 29(2):177-8. PubMed ID: 19090488
[No Abstract] [Full Text] [Related]
17. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody-associated congenital heart block: a rare cause of persistent fetal bradycardia.
Nigam A; Ahmad A
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26002776
[TBL] [Abstract][Full Text] [Related]
19. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.
Gladman G; Silverman ED; Yuk-Law ; Luy L; Boutin C; Laskin C; Smallhorn JF
Am J Perinatol; 2002 Feb; 19(2):73-80. PubMed ID: 11938480
[TBL] [Abstract][Full Text] [Related]
20. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review.
Hutter D; Silverman ED; Jaeggi ET
Scand J Immunol; 2010 Sep; 72(3):235-41. PubMed ID: 20696021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
